Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 24 min ago
Peer-reviewedLicence not statedFuture Medicinal Chemistry

Heterocyclic scaffolds targeting IDO1: progress in medicinal chemistry and clinical development

  • Ankush Kumar1
  • Vishakha Sharma2
  • Rajiv Patel3
  • Rajwinder Kaur1
  • Rohit Bhatia1
  1. 1Department of Pharmaceutical Chemistry, Chitkara College of Pharmacy, Chitkara University, Rajpura, India
  2. 2Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, India
  3. 3Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, India
Read full textDOICite

Related

  1. Identification of Novel Potential Tubulin-Targeting Heterocyclic Compounds via Integrated Virtual Screening and In Vitro Studies
    Yaroslava Deyak, Dmytro Khylyuk, Rostyslav Dudchak +12
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCDOAJ
  2. Domain-resolved epitope mapping of B7-H3-targeting VHH-Fcs defines isoform-selective binders for antibody-drug conjugate development
    X. Fang, B. Chalopin, S. S. Gokturk +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. 891 Pre-clinical development of a best-in-class bispecific T cell engager targeting a highly abundant peptide for the treatment of melanoma
    Samuel Ward, David Cook, Xiaoyan Pan +32
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH.
    Sarandeep Kaur, Sladjana Dukic-Stefanovic, Lucie Arnaud +5
    Journal of labelled compounds & radiopharmaceuticalsPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  5. Development of dual SST₂/SST₅ targeting radioligands through rational structural design.
    Fabienne Spinnler, Luigi Del Pozzo, Lennart Bohrmann +6
    RSC medicinal chemistryPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{kumar2026heterocyclic,
  title = {{Heterocyclic scaffolds targeting IDO1: progress in medicinal chemistry and clinical development}},
  author = {Ankush Kumar and Vishakha Sharma and Rajiv Patel and Rajwinder Kaur and Rohit Bhatia},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  month = sep,
  doi = {10.1080/17568919.2026.2741229},
  url = {https://doi.org/10.1080/17568919.2026.2741229},
}
RIS
TY  - JOUR
TI  - Heterocyclic scaffolds targeting IDO1: progress in medicinal chemistry and clinical development
AU  - Ankush Kumar
AU  - Vishakha Sharma
AU  - Rajiv Patel
AU  - Rajwinder Kaur
AU  - Rohit Bhatia
PY  - 2026
DA  - 2026/09/30
JO  - Future Medicinal Chemistry
DO  - 10.1080/17568919.2026.2741229
UR  - https://doi.org/10.1080/17568919.2026.2741229
SN  - 1756-8919
SN  - 1756-8927
ER  -